Contents
Download PDF
pdf Download XML
49 Views
30 Downloads
Share this article
Case Report | Volume 15 Issue 12 (None, 2025) | Pages 468 - 470
CLINICAL COURSE AND MANAGEMENT OF ACUTE RESPIRATORY INJURY INDUCED BY HCL FUMES IN A HOUSEHOLD SETTING: A RARE CASE REPORT
 ,
 ,
1
Department of Respiratory Medicine, ESIC Medical College and Hospital, Alwar, Rajasthan – 301030
2
Senior Resident, Department of Respiratory Medicine, ESIC Medical College and Hospital, Alwar, Rajasthan – 301030
Under a Creative Commons license
Open Access
Received
Oct. 1, 2025
Revised
Oct. 29, 2025
Accepted
Nov. 17, 2025
Published
Dec. 29, 2025
Abstract

We report a case of chemical pneumonitis in a 41-year-old female resident of Rajasthan, following brief inhalation exposure to 31% concentrated hydrochloric acid (HCl) fumes while cleaning her bathroom floor. She presented with acute onset of shortness of breath, blood tinged sputam and cough. On admission, SpO2 was 89% on room air, pulse rate 124 bpm, and blood pressure 126/84 mmHg, with bilateral middle and lower zone crepitations and rhonchi. Chest x-ray revealed bilateral middle and lower zone opacities and HRCT s/o diffuse alveolar hemorrhage. She was treated with humidified oxygen via nasal prongs at 6 L/min (FiO2 44%), nebulization with bronchodilators, intravenous methylprednisolone, and prophylactic antibiotics. Clinical and radiological improvement was noted by day 7. This case highlights the importance of prompt supportive care with steroids and antibiotics in HCl-induced chemical pneumonitis.1,2

Keywords
INTRODUCTION

Hydrochloric acid (HCl) is a widely used industrial and household chemical known to release corrosive, irritant vapors upon exposure to air. These acidic fumes can cause significant respiratory tract injury when inhaled, leading to chemical pneumonitis and, in severe cases, acute respiratory distress syndrome (ARDS).2,3 Inhalational injury from chemicals such as chlorine and hydrochloric acid has been described predominantly in occupational settings; however, cases from household exposures are emerging, especially in industrial hubs, where concentrated HCl products pose public health risks due to accidental inhalation during routine cleaning.4,5

 

Diagnosis of HCl-induced chemical pneumonitis relies primarily on clinical history, symptomatology, and radiological evidence because no specific biomarkers exist for HCl inhalation.7 Treatment remains predominantly supportive, encompassing oxygen therapy, corticosteroids, bronchodilator nebulization, and prophylactic antibiotics to prevent secondary infections.9,10

 

Case Presentation

A 41-year-old woman from north-east Rajasthan, exposed to 31% concentrated hydrochloric acid fumes for approximately one minute while cleaning a bathroom floor in a poorly ventilated area, developed acute shortness of breath, cough, and blood tinged sputam production.

 

On admission: SpO₂ of 89% on room air, pulse rate 124 bpm, blood pressure 126/84 mmHg, on auscultation bilateral crepitations and rhonchi in middle and lower lung zones.

 

Treatment included humidified oxygen via nasal prongs at 6 L/min (FiO2 44%), nebulized bronchodilators, intravenous methylprednisolone 40 mg twice daily, and prophylactic intravenous antibiotic. Symptomatic treatment continued for 7 days.

Laboratory investigations showed leukocytosis with neutrophilia, mild anemia (Hb 9.3 g/dL), elevated CRP (9.7 mg/L), and slightly raised AST, ALT, ALP. Arterial blood gases revealed mild hypoxemia (PaO2 80 mmHg) with pH 7.43. Infectious workup including tuberculosis serology was negative.

 

Chest X-ray and high-resolution CT thorax demonstrated diffuse alveolar opacification and GGO noted in both lungs in perihilar region with sparing of sub pleural & lung apices s/o diffuse alveolar hemorrhage consistent with chemical pneumonitis.

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 1: HRCT thorax on admission demonstrated diffuse alveolar opacification and GGO noted in both lungs in perihilar region with sparing of sub pleural & lung apices s/o diffuse alveolar hemorrhage consistent with chemical pneumonitis

 

By day 7, SpO2 improved to 97% on room air, pulse rate reduced to 84 bpm, blood pressure normalized at 124/82 mmHg. Mild crepitations remained bilaterally. The patient was stable and discharged with inhaled corticosteroids and pulmonary rehabilitation and follow-up.

 

DISCUSSION

HCl inhalation causes chemical pneumonitis through corrosive injury to airways and alveoli, causing inflammation, edema, hemorrhage, and impaired gas exchange. Severity relates to concentration, exposure duration, and ventilation.2,7 Supportive management is key. Oxygen supplementation corrected hypoxemia via nasal prongs (FiO2 44%).9 Nebulized bronchodilators relieve airway obstruction; corticosteroids reduce inflammation and lung injury progression.8,10 Prophylactic antibiotics prevent secondary infection.1 Inhaled corticosteroids combined with bronchodilators improve lung compliance and oxygenation after chlorine or HCl inhalation.10,11 Nebulized sodium bicarbonate may neutralize acid fumes, reducing lung injury, but lacks standardized dosing and clear evidence.12-14 Diffuse alveolar hemorrhage visible on HRCT indicates severe membrane injury. Timely supportive care enabled near-complete recovery by day 7. Long-term follow-up is important for detecting reactive airway dysfunction syndrome, which requires prolonged bronchodilator therapy.2,9 This case adds to sparse Indian data on household HCl inhalation injuries, highlighting need for public education about safe chemical use, ventilation, protective equipment, and clinician awareness for early recognition and multidisciplinary care.4,9

CONCLUSION

Brief household exposure to concentrated HCl fumes can cause serious chemical pneumonitis and diffuse alveolar hemorrhage. Early diagnosis through history and imaging combined with supportive oxygen, corticosteroids, bronchodilators, and antibiotics leads to good outcomes. Public health measures and clinician vigilance are key to reducing morbidity.

 

Acknowledgement

I would like to thank Dr. Ayush Senger, Dr. Jay Manchanda for their guidance in paper writing.

No conflict of interest or financial support declared.

REFERENCES

1.       Roslan NL, Urgena K, Abd Wahab M. The Toxic Fumes: A Case Report of an Accidental Inhalation of HCL 33%. Asia Pac J Med Toxicol. 2022;12(1):33-37.

2.       Medical Management Guidelines for Hydrogen Chloride [Internet]. ATSDR; 2014. Accessed November 15, 2022. https://www.atsdr.cdc.gov/MHMI/mmg173.pdf

3.       Thomas HL, Murray V. Review of acute chemical incidents involving exposure to chlorine associated with swimming pools in England and Wales, June–October 2007. J Public Health (Oxf). 2007;30(4):391-397.

4.       Rajasuriar R. Profile of poisoning admissions in Malaysia. Hum Exp Toxicol. 2007;26(1):73-81.

5.       Ho MP. Chlorine gas exposure manifesting acute lung injury. J Intern Med Taiwan. 2010;21:210-215.

6.       White CW, Martin JG. Chlorine gas inhalation: human clinical evidence of toxicity and experience in animal models. Proc Am Thorac Soc. 2010;7(4):257-263.

7.       Gunnarsson M, Walther SM, Seidal T, Lennquist S. Effects of inhalation of corticosteroids immediately after experimental chlorine gas lung injury. J Trauma. 2000;48(1):101-107.

8.       Saeed O, Boyer NL, Pamplin JC, et al. Inhalation injury and toxic industrial chemical exposure. Mil Med. 2018;183(9-10):130-132.

9.       Wang J, Zhang L, Walther SM. Administration of aerosolized terbutaline and budesonide reduces chlorine gas–induced acute lung injury. J Trauma. 2004;56(4):850-862.

10.    Vajner JE 3rd, Lung D. Acute chlorine gas inhalation and the utility of nebulized sodium bicarbonate. J Med Toxicol. 2013;9(3):259-265.

11.    Bosse GM. Nebulized sodium bicarbonate in the treatment of chlorine gas inhalation. J Toxicol Clin Toxicol. 1994;32(3):233-241.

12.    Aslan S, Kandiş H, Akgun M, et al. The effect of nebulized NaHCO3 treatment on reactive airway dysfunction syndrome due to chlorine gas inhalation. Inhal Toxicol. 2006;18(11):895-900.

13.    Brodier EA, Raithatha M, Kannan S, Karunasekara N. Use of nebulised N-acetylcysteine as a life-saving mucolytic in intensive care: a case report. J Intensive Care Soc. 2020;21(4):296-298.

14.  14.  Faria VS, da Silva SAEHC, Marchini JFM. Reactive airways dysfunction syndrome following inhalation of hydrogen chloride vapor. Autops Case Rep. 2021;11:e2021266.

 

Recommended Articles
Research Article
Utilization and Outcome Analysis of ECMO Modalities in a High-Volume Indian Critical Care Unit: A Multicentric Retrospective Study
...
Published: 29/12/2025
Download PDF
Research Article
Integrated Radiologic-Pathologic Predictors of Triple-Negative Breast Cancer: Insights from an Indian Cohort
...
Published: 29/12/2025
Download PDF
Research Article
Intraoperative Parameters and Postoperative Outcomes in Chronic Tonsillitis Patients Undergoing Coblation Tonsillectomy Compared with Conventional Tonsillectomy: A Prospective Comparative Study
...
Published: 26/12/2025
Download PDF
Research Article
Bentall Procedure: A Ten-Year Single-Center Case Series of 15 Patients
...
Published: 29/12/2025
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.